Radiation%20Therapy
Showing 26 - 50 of >10,000
Metastatic Malignant Tumor in the Brain Trial in Rochester (Questionnaire Administration, Stereotactic Radiosurgery)
Recruiting
- Metastatic Malignant Neoplasm in the Brain
- Questionnaire Administration
- Stereotactic Radiosurgery
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Pleural Mesothelioma Trial in Rochester (Immunotherapy, Quality-of-Life Assessment, Stereotactic Body Radiation Therapy)
Recruiting
- Pleural Mesothelioma
- Immunotherapy
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 4, 2023
Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity
Not yet recruiting
- Nasopharyngeal Carcinoma
-
Fuzhou, Fujian, ChinaDepartment of radiation oncology, Fujian cancer hospital
Nov 16, 2023
Diffuse Midline Glioma, H3 K27M-Mutant Trial in Rochester (Hypofractionated Radiation Therapy, Quality-of-Life Assessment,
Recruiting
- Diffuse Midline Glioma, H3 K27M-Mutant
- Hypofractionated Radiation Therapy
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 6, 2023
Prostate Cancer Trial in Philadelphia (Proton Beam Radiation Therapy, Quality-of-Life assessment, Questionnaire Administration)
Terminated
- Prostate Cancer
- Proton Beam Radiation Therapy
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jan 30, 2023
Cervical Carcinoma, Endometrial Carcinoma, Endometriosis Trial in Scottsdale, Jacksonville, Rochester (Quality-of-Life
Recruiting
- Cervical Carcinoma
- +3 more
- Quality-of-Life Assessment
- +2 more
-
Scottsdale, Arizona
- +2 more
Jan 5, 2023
COVID-19 Pneumonia Trial (Low-Dose Radiation Therapy)
Not yet recruiting
- COVID-19 Pneumonia
- Low-Dose Radiation Therapy
- (no location specified)
Jan 22, 2023
Prostatic Tumors, Prostate Cancer, Prostate Adenocarcinoma Trial run by the National Cancer Institute (NCI) (18F-DCFPyL,
Not yet recruiting
- Prostatic Neoplasms
- +2 more
- 18F-DCFPyL
- Stereotactic Body Radiation Therapy
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Hepatocellular Carcinoma Non-resectable Trial (Selective Internal Radiation Therapy with 188Re-SSS lipiodol)
Not yet recruiting
- Hepatocellular Carcinoma Non-resectable
- Selective Internal Radiation Therapy with 188Re-SSS lipiodol
- (no location specified)
Mar 22, 2023
Ductal Breast Carcinoma in Situ, Invasive Breast Cancer, Early-stage Breast Cancer Trial in Mérida (Hypofractionated
Recruiting
- Ductal Breast Carcinoma in Situ
- +6 more
- Hypofractionated radiotherapy
-
Mérida, Yucatán, MexicoUnidad Medica de Alta Especialidad
Nov 7, 2022
Metastatic Tumor to the Spine, Metastatic Tumor Trial in Cleveland (Conventional external beam radiation therapy dose (EBRT),
Recruiting
- Metastatic Neoplasm to the Spine
- Metastatic Neoplasm
- Conventional external beam radiation therapy dose (EBRT)
- +2 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 24, 2023
Uterine Cervical Tumors Trial in Beijing (hydrogel spacer)
Recruiting
- Uterine Cervical Neoplasms
- hydrogel spacer
-
Beijing, ChinaPeking Union Medical College Hospital
Jun 5, 2023
Radiotherapy Side Effect, NSCLC, ALK Gene Mutation Trial in Stockholm (SBRT/SRS/radiation therapy)
Not yet recruiting
- Radiotherapy Side Effect
- +2 more
- SBRT/SRS/radiation therapy
-
Stockholm, SwedenKarolinska University Hospital
Feb 16, 2023
Soft Tissue Sarcoma Trial in France (Patients will receive the hypofractionated radiation therapy (30 Gy in 5 fractions) prior
Not yet recruiting
- Soft Tissue Sarcoma
- Patients will receive the hypofractionated radiation therapy (30 Gy in 5 fractions) prior to surgery.
- Patient will undergo surgery before receive the adjuvant hypofractionated radiation therapy (40 Gy in 15 fractions).
-
Bordeaux, France
- +10 more
Aug 28, 2023
Pancreatic Cancer Trial in Saint Louis (Daily Adaptive External Beam Radiation Therapy)
Recruiting
- Pancreatic Cancer
- Daily Adaptive External Beam Radiation Therapy
-
Saint Louis, MissouriWashington University, St. Louis
Mar 7, 2023
Blood and Urine From Patients Undergoing Radiation Therapy
Enrolling by invitation
- Carcinoma
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Metastatic Prostate Adenocarcinoma, Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Rochester
Active, not recruiting
- Metastatic Prostate Adenocarcinoma
- +6 more
- Intensity-Modulated Radiation Therapy
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Astrocytoma, Oligodendroglioma, Adult, Glioma, Malignant Trial in Saint Louis (temporally-modulated pulsed radiotherapy (TMPRT))
Recruiting
- Astrocytoma
- +2 more
- temporally-modulated pulsed radiotherapy (TMPRT)
-
Saint Louis, MissouriWashington University School of Medicine
Jan 19, 2023
Failure in Patients Undergoing Radiation Therapy for Localized
Active, not recruiting
- Prostate Cancer
- Radiation Toxicity
- medical chart review
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 9, 2022
Lung Cancer Trial (Healthy lung sparing treatment plan)
Not yet recruiting
- Lung Cancer
- Healthy lung sparing treatment plan
- (no location specified)
Nov 7, 2023
Oligometastatic Renal Cell Carcinoma Trial in Houston (Pembrolizumab, Radiation therapy)
Not yet recruiting
- Oligometastatic Renal Cell Carcinoma
- Pembrolizumab
- Radiation therapy
-
Houston, TexasM D Anderson Cancer Center
Aug 21, 2023
Anal Squamous Cell Carcinoma Trial (Radiotherapy - Low risk group, Radiotherapy - Standard risk group, Radiotherapy -
Not yet recruiting
- Anal Squamous Cell Carcinoma
- Radiotherapy - Low risk group
- +3 more
- (no location specified)
Sep 18, 2023
Pancreatic Cancer Trial in Seoul (Preoperative Stereotactic body radiation therapy (SBRT), Pancreatic resection, Adjuvant
Recruiting
- Pancreatic Cancer
- Preoperative Stereotactic body radiation therapy (SBRT), Pancreatic resection, Adjuvant Chemotherapy
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
Jan 10, 2023
Early-stage Breast Cancer Trial in Brno (APBI, WBI)
Completed
- Early-stage Breast Cancer
- APBI
- WBI
-
Brno, Czech Republic, CzechiaMasaryk Memorial Cancer Institute
Aug 17, 2023